Enzymotec has won Australian patent for its Omega-sterols ingredient, a hybrid of phytosterols and omega-3s.
Subscribe to our email newsletter
Omega-sterol was clinically proven to be effective for blood lipid control and for supporting healthy levels of both blood triglycerides and LDL-cholesterol (bad cholesterol) in humans, the company said.
According to Naturalproductsinsider, Omega sterols were also clinically proven to be better than standard sterol-esters since they do not hinder the absorption of certain vitamins, such as Vitamin E.
The patent covers the use of this ingredient as a functional food for diabetics and is one of five patents covering properties, composition and methods of use for this ingredient.
Enzymotec omega-3 category manager Eyal Afergan said that the product and its patent applications are an essential part of their strategy.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.